This marked the fourth consecutive quarter where the drugstore chain reported negative comparable store sales. Walgreens' chief drugstore rivals, CVS and Rite Aid, achieved positive front-end comp sales for the same quarters. The report cites a number of possible contributing factors that may be affecting Walgreens' in-stock positions, including reduced staff levels, inadequate inventory, and a lack of focus on domestic operations as the company pursues global expansion.